STUDresearch · Peptide
N-Acetyl Selank Amidate
Also known as
N-Acetyl Selank · NA-Selank Amidate · NA-Selank · NA Selank Amidate · Acetyl-Selank Amidate · N-Acetyl-Selank-Amidate · NA Selank · Ac-Thr-Lys-Pro-Arg-Pro-Gly-Pro-NH2 · Ac-TKPRPGP-NH2 (sequence shorthand) · N-Ac-Selank-NH2
Community talk. May be wrong. Not medical advice. Not a protocol. Not for human or animal use.
Peptide
Some talk
Systemic
Intranasal
Cognitive / nootropic peptides
Systemic CNS framing — research-chem and community use is almost entirely intranasal for anxiolytic/nootropic goals, not local tissue repair.
What people say
N-Acetyl Selank Amidate is a dual-capped Selank analog sold as a more stable, longer-lasting version. Direct human trials and pharmacokinetics for this exact analog were not identified.
Doses people talk about
Spray concentration, delivered amount, product identity and author units are uncertain. Plain Selank product or trial amounts cannot define an amidate dose.
How it may feel
Inspected reports range from no effect to slight body sensations or a brief intense accidental-exposure reaction. A separate review of an identity-ambiguous N-acetyl product described as acetate reported a four-hour dissociative feeling; another commenter explicitly naming amidate reported an opioid-like feel and symptoms after running out.
Inspected lower-to-mid reports200–550 mcg/day intranasal
One N-A-Selank author described about 200 mcg once or twice daily and later 400–550 mcg once daily, with no notable effect at lower amounts and only a possible slight sensation at higher amounts; exact product identity was not established.
Inspected higher daily report600–900 mcg/day intranasal
One commenter described this range and later said 900 mcg during an anxiety spike felt like nothing; the account does not establish effectiveness or safety.
Accidental single-exposure report750 mcg intranasal once
A different commenter described an intense weak/distant-body sensation lasting about 15–20 minutes after an accidental amount.
Half-life & effect duration
- Half-life in the body
- Capped variant · vendor estimateAbout 10–20 minutes
- Felt duration people report
- Marketed effect windowAbout 4–6 hours
- Some accountsNo notable effect or only a slight sensation
- Accidental-exposure accountIntense reaction for about 15–20 minutes
- N-acetyl product · identity unclearAbout 4 hours of dissociation in a separate review
Cycles people discuss
Community and vendor notes describe 10–14-day and 14–21-day courses, often borrowed from plain Selank. A separate discussion contrasts 14 days with six weeks and includes as-needed use explicitly naming amidate; no analog-specific trial validates those calendars.
Timing
Morning or daytime use appears alongside concern about flatness and sleep debt; later Selank-class use also appears in Semax pairings. Reports include one to three daily nasal administrations and as-needed use, without a standardized clock.
Stacks
Community notes place NA-Semax Amidate, plain Semax, Noopept, caffeine, racetams and other calming agents beside this product. Product identity and co-use make benefits or adverse effects hard to attribute to exact amidate.
Watch for
Cognitive dulling / low mood: Minority Selank-class logs of sedation, cognitive impairment, or depression-like flatness — sometimes when stacked aggressively with other nootropics.
Tap a line to jump into the full notes. Research only — may be wrong.
Timing context & sources
Half-life in the body
No dependable human elimination half-life for N-Acetyl Selank Amidate was identified.
The repeated two-minute number is reported for parent Selank in vitro degradation. Structural capping and vendor duration claims do not supply a human analog concentration-time curve.
Secondary parent-peptide review, in-vitro endpoint and no direct human capped-analog PK; community products are not independently verified.
- Neuroscience and Medicine — A New Generation of Drugs: Synthetic Peptides Based on Natural Regulatory Peptides (opens in a new tab)Section 4.3, page 14: reports an approximately two-minute Selank half-life from in vitro experiments, followed by secondary statements about intranasal parent Selank detection and tissue distribution.Secondary review, parent Selank rather than N-Acetyl Selank Amidate, and an in-vitro degradation value rather than direct human plasma elimination PK.
Felt duration people report
Reports conflict from no notable effect to a slight sensation or an intense 15–20-minute accidental-exposure reaction; a separate identity-ambiguous N-acetyl product review described roughly four hours of dissociation.
One different commenter explicitly naming amidate described an opioid-like feel and mild symptoms after running out; that post cannot be merged with the identity-ambiguous review author's experience or treated as established withdrawal.
Few uncontrolled accounts, unit and N-acetyl product-identity ambiguity in one review, different authors, no verified product identity or comparator, and frequent plain-Selank/analog naming confusion.
- r/Nootropics — N-A-Selank experiences and odd effects from higher doses (opens in a new tab)Original post: about 200 mcg once or twice daily produced no notable effect and 400–550 mcg once daily only a possible slight body sensation. A separate commenter described an accidental 750 mcg exposure with an intense weak/distant-body sensation for 15–20 minutes.Uncontrolled reports from different people, unverified identity and delivered amount, no comparator and uncertain causal attribution for eye strain or twitching.
- r/Nootropics — Review of Selank acetate and N-Acetyl Selank Amidate (opens in a new tab)Original author distinguishes plain Selank from an N-acetyl product, calls the latter “N-Acetyl-Selank Acetate,” writes ambiguous mg units, and describes no anti-anxiety benefit plus about four hours of slight dissociation. A different commenter explicitly names NA-Selank Amidate and describes an opioid-like feel and mild symptoms after running out.Unit typo or ambiguity, unresolved exact product identity for the original author, separate commenters, unverified products and no comparator; the withdrawal-like report came from a commenter with long-term opioid use and is not the original author's outcome.
- r/Nootropics — How do you cycle your Selank? (opens in a new tab)Discussion includes one N-Acetyl Selank Amidate user reporting 600–900 mcg/day and later saying a 900 mcg amount during an anxiety spike felt like nothing; the thread also asks about 14-day versus six-week courses.Uncontrolled single-person amount and null response, unverified product, mixed plain-versus-amidate discussion and vendor/source talk elsewhere in the thread.
What people say
- Anxiolytic (primary hook): Less baseline anxiety, rumination, social edge, and “noise” without heavy benzo-style sedation — the same core claim as plain Selank, applied to this analog by default. forum
- Duration / stability hope: Chosen over plain Selank specifically because dual capping is said to slow breakdown and stretch coverage per dose or per course day — a community PK bet, not a published NA-Amidate half-life table. forum
- Calm focus role: Stacked as the calm half of Semax / NA-Semax Amidate pairings — focus from Semax-class, composure from Selank-class. forum
- Clarity after anxiety drops: Clearer thinking once edge falls — often framed as secondary to anxiolysis rather than pure cognitive enhancement (weaker pure nootropic reputation than Semax/NASA). forum
- Stress course effect: Multi-day stress steadiness and “still functional under load” more than a single-dose buzz or euphoria. anecdote
- Vs plain Selank typology: Community shorthand — same “feel family,” bet on longer stability / possibly lower frequency or lower mcg for similar effect; some users prefer plain, some prefer amidate, some report no difference (confounded by source quality). forum
- Vs Semax / NASA: Selank-class = calm / anxiolytic; Semax-class = activating / focus. Useful stacking language, not a Western head-to-head RCT. forum
- Stack halo warning: Co-use with NA-Semax Amidate, caffeine, racetams, sleep changes, and stress reduction often co-occurs — single-agent credit is unreliable. forum
- Parent Selank GAD / neurasthenia (borrowed evidence): Zozulia et al. 2008 (PMID 18454096) compared plain Selank vs medazepam in GAD/neurasthenia; anxiolytic effects described as similar on standard scales, with Selank also showing antiasthenic / mild psychostimulant properties the benzo arm lacked, and leu-enkephalin changes correlating with improvement. This is parent-molecule data, not NA-Amidate RCTs. trial
- Non-sedating / non-dependence narrative (borrowed): Russian clinical summaries for plain Selank claim anxiolysis without classic benzo amnesia, muscle relaxation, tolerance, or withdrawal packages — forums apply this story to NA-Selank Amidate by analogy; long-term gray-market self-use is not proven by that claim. trial
- Learning / memory (preclinical, parent): Rodent learning/memory and hippocampal BDNF work on plain Selank is recycled in NA-Selank marketing; not NA-Amidate-specific animal packages. animal
- Enkephalin angle (parent lab work): Selank inhibits serum enkephalin-degrading enzymes in vitro/ex vivo work — used online to explain calm without opioid sedation; assumed (not proven) for the capped analog. trial
- Vs benzos (user language): “Takes the edge off without destroying drive or next-day fog” — anecdotal comparison only; not medical equivalence. anecdote
- Immune / cytokine (secondary, parent): Parent Selank has IL-6 / T-helper balance discussion in Russian clinical framing; secondary in NA-Selank Amidate threads, which stay anxiety-first. trial
Doses people talk about
- Observed N-acetyl Selank nasal amounts: One forum user explicitly identifying amidate described 600–900 mcg/day and later said 900 mcg during an anxiety spike felt like nothing; a separate N-A-Selank author described about 200 mcg once or twice daily and 400–550 mcg once daily without establishing exact product identity. forum
- Preserved lower-amount discussion: The frozen community note records historical guidance of about 300 mcg and sometimes half that amount. Newly inspected reports do not independently verify the half-dose claim; product identity and delivered spray amount remain uncertain. forum
- Broader community nasal daily band: Roughly ~300–900 mcg/day total split 1–3× is the densest Western discussion cluster for this analog; higher totals sometimes appear when people copy plain-Selank upper clinical figures onto the wrong molecule. forum
- SubQ (minority for the Selank class): Injectable Selank-class talk often ~150–300 mcg/day SC (starting ~150–200 mcg; “sweet spot” logs often ~200–250 mcg; upper forum talk ~300 mcg), sometimes once daily. NA-Amidate-specific SubQ charts are thinner; most NA-Amidate threads stay nasal. forum
- Potency-per-mg claim: Some vendor writeups say NA-Selank Amidate is “higher potency per mg” than plain Selank because of stability — if true, blind 1:1 copy of high plain-Selank mcg totals onto the amidate would be aggressive; community practice is still often in the same hundreds-of-mcg band. Not formal PK proof. forum
- Timing: Anytime for pure calm goals; some prefer morning or daytime so any flatness is not layered on sleep debt. Unlike Semax/NASA, evening Selank-class is less consistently flagged for insomnia — but flat/unmotivated reports still exist. forum
- As-needed vs scheduled: High-stress days only vs daily through a fixed ~10–14 (or ~14–21) day course then stop — both patterns common. Single morning-only dosing is sometimes described as leaving afternoon gaps if all-day coverage is the goal. forum
- Calibration / math traps: Confusing drops vs pumps, mg vs mcg, plain vs amidate labels, and dead volume on spray bottles make labeled mcg ≠ delivered mcg. forum
- Uncertainty / quality: Fill errors, underdosed sprays, mislabeled analog (plain vs acetyl-only vs acetyl-amidate), and multi-use bottle contamination mean protocol numbers are only as good as the product. forum
- Framing: Community research-discussion ranges only — not medical advice, not prescriptions, not validated Western protocols. Gray-market mcg labels and pump claims are not pharmacy-grade identity. No official N-Acetyl Selank Amidate dosing guideline exists because the analog lacks its own clinical program. forum
- Nasal vs SubQ lore: Injection discussed at lower mcg than nasal on assumed bioavailability grounds; nasal still dominates for “CNS / nose-to-brain” framing and for matching how the parent drug is studied/sold. Circulating bioavailability percentages on vendor blogs are usually not primary PK citations. forum
- Parent Selank clinical upper band (different molecule): Secondary summaries of Russian/clinical use cite up to ~2,700 mcg/day intranasal split 2–3× for multi-week courses (e.g. GAD protocol language in abstracts). That is plain Selank study/product culture, not a proven NA-Amidate ceiling. trial
- Parent Selank Russian product form (different molecule — reference only): 0.15% nasal drops; label-style posology widely reproduced as 2 drops per nostril 3× daily for ~14 days; secondary sources disagree on exact mcg math (commonly cited daily totals cluster ~450–900 mcg/day depending on assumed mcg/drop). Do not treat blog “official mcg” as primary labeling. trial
How it may feel
- Acute nasal reports: One author noticed nothing at about 200 mcg once or twice daily and only a possible slight body sensation at 400–550 mcg; another commenter described an intense 15–20-minute reaction after an accidental 750 mcg exposure. forum
- Same-day reports conflict: One review of an identity-ambiguous N-acetyl product described as acetate reported slight dissociation lasting about four hours; another N-A-Selank author reported no notable effect across 200–550 mcg exposures. A separate commenter explicitly naming amidate described an opioid-like feel and mild symptoms after running out. forum
- Days 1–3: Early anxiety drop for responders; nasal irritation, post-nasal drip, or mild head pressure often noticed before mood claims. Occasional first-dose oddities (flush, brief HR awareness, drip-related nausea) appear in Selank-class logs. forum
- Days 3–7: Common first “is this working?” checkpoint — less rumination, easier high-stress social/work days, still no euphoria expected. forum
- Week 1–2 (course window): Mid-course reassessment for cumulative stress resilience; 10–14 day blocks dominate discussion, mirroring parent Selank course culture. forum
- Weeks 2–3 / extended blocks: Some continue toward ~14–21 days or ~2–3 weeks; plateau, flatness, “already got what I needed,” or schedule end are common stop reasons. forum
- End of course / washout: Many stop on a fixed calendar; residual calm can linger days for some; others fade within 1–2 days. Community off periods often days to a few weeks. anecdote
- No change by ~10–14 days: Forums point to product authenticity, spray mcg math, sleep, caffeine, and expectations — not automatic dose stacking. forum
Cycles people discuss
- Most common community course: ~10–14 days nasal, explicitly mirroring parent Selank / Russian product course language. forum
- Vendor/sample NA protocol language: Up to ~14 days on, then minimum ~1 week off before another two-week-style course if repeating — appears in research-chem guide sample protocols. forum
- Community extension: ~14–21 days frequently; some protocol blogs drift toward ~2–3 weeks or ~30-day frameworks borrowed from broader peptide culture — longer NA-Amidate courses have no dedicated trial backbone. forum
- Time off (forum practice): Days to a few weeks between re-runs is standard; continuous multi-month daily use is less common in careful logs than pulsed stress-window use. forum
- On/off symmetry talk: “Match time-off roughly to time-on” appears as convenience pattern, not a hard PK rule for this analog. forum
- As-needed pulse: Acute high-anxiety or performance days without a full multi-week course — reported after someone knows their response. anecdote
- With Semax / NA-Semax Amidate: Usually same calendar block (both on together for the “calm focus” pair), not staggered multi-week cycles. forum
- Re-runs: Before exams, travel, launches, or seasonal high-demand work more than open-ended daily maintenance. forum
- Tolerance / desensitization talk: No classic benzo-withdrawal package in community lore; some secondary writeups speculate long continuous GABA-system use could blunt response or rebound anxiety — data for NA-Amidate specifically is essentially none; short courses are the conservative discussion norm. forum
- Parent Selank washout talk (borrowed): Secondary Russian-product language often mentions ~1–3 weeks between courses if repeating; some summaries mention longer spacing. Applied to NA-Amidate by analogy. trial
Timing
- NA-Amidate claim: Dual capping (acetyl + amide) hypothesized to slow proteolytic degradation vs plain Selank, potentially prolonging exposure and reducing needed dose frequency in experimental models. Direct published human PK for N-Acetyl Selank Amidate is sparse/absent; treat longer-half-life claims as structure analogy + vendor lore. forum
- Still split dosing in practice: Even with “longer lasting” marketing, community logs and sample charts stay 1–3× daily nasal — not weekly depot-style. forum
- Subjective onset: Often ~15–60 minutes nasal for responders (anecdote; not controlled human PK for this analog). anecdote
- Subjective per-dose window: A few hours of noticeable calm coverage for some; others describe a quieter multi-day baseline building across a course more than discrete “kicks.” forum
- Do not 1:1 copy charts: Plain Selank clinical mcg totals and NA-Selank Amidate vendor pumps are different product cultures; high plain-Selank trial figures are not automatically “correct” for the capped analog. forum
- Parent Selank in vitro degradation, not analog human PK: A secondary review reports an approximately two-minute Selank half-life from in vitro experiments. It does not establish human plasma elimination for plain Selank or N-Acetyl Selank Amidate. trial
- Parent nasal absorption notes (product literature / secondary): Russian product summaries describe rapid nasal absorption, plasma detection within ~30 seconds, brain tissue distribution, and progressive plasma decline over minutes — used to justify intranasal multi-dose design. trial
- Why effects can outlast plasma: Downstream signaling stories (GABA modulation, enkephalin pathways, gene expression / BDNF changes in animals on parent Selank) are used to explain hours-to-days functional effects after brief peptide exposure. animal
- Course vs acute: Acute situational calm vs multi-day “stress resilience” after repeated administrations — both claimed; course framing is closer to how Russian Selank products are labeled. forum
- Route preference: Intranasal preferred for CNS-oriented goals in research design and community practice; oral dismissed for peptide instability / poor delivery framing. trial
More on what it is
- What it is: Dual-capped Selank analog: N-terminal acetylation + C-terminal amidation on the parent heptapeptide sequence (commonly written Ac-Thr-Lys-Pro-Arg-Pro-Gly-Pro-NH2). Same tuftsin + Pro-Gly-Pro core as plain Selank; ends are chemically protected. Gray-market research chemical — not an approved drug. forum
- Why people use it: Sold and searched as “longer-lasting / more stable Selank” for anxiety and calm focus; often stocked as the calm counterpart to N-Acetyl Semax Amidate (NASA). forum
- What the caps are supposed to do: N-acetylation slows aminopeptidase attack; C-amidation slows carboxypeptidase attack and is a common neuropeptide motif; vendor/forum language also claims better CNS exposure and higher potency-per-mg than plain Selank. These are structure–analogy claims, not published NA-Selank Amidate human PK. forum
- Not: Not FDA- or EMA-approved; not Russian pharmacy Selank 0.15%; not a benzodiazepine; not dose-identical to plain Selank or to NA-Semax Amidate; not proven longer-lasting in controlled human PK just because the ends are capped. forum
- Three-name trap: Plain Selank ≠ N-Acetyl Selank (acetyl only) ≠ N-Acetyl Selank Amidate (acetyl + amide). Vendors and labels sometimes blur these; community logs often do too. forum
- Mechanism talk (inherited): Borrowed from parent Selank — GABA-A allosteric modulation narrative, enkephalinase inhibition / leu-enkephalin support, monoamine/serotonin shifts, hippocampal BDNF (rodent), secondary tuftsin-lineage immune/cytokine talk. Forums compress to “calmer GABA/stress peptide, not a stim.” trial
- Evidence honesty: Human clinical density is almost entirely plain Selank (Russian GAD/neurasthenia work, registered 0.15% nasal product). Direct trials, formal PK, and regulatory history for N-Acetyl Selank Amidate specifically are sparse to absent in English literature; most “effects” and safety language are extrapolated. trial
- Lens: Vendor spray charts, “benzo calm without fog,” and 300 mcg/pump protocols are discussion/commerce data — research-only framing, not prescriptions. forum
Stacks
- NA-Semax Amidate + NA-Selank Amidate (dominant pair): Classic research-chem “calm focus” dual — NASA for attention/drive, NA-Selank Amidate for anxiolysis. Usually independent full nasal doses of each in the same course window, not a fixed mg:mg pre-blend. forum
- Plain Semax + Selank-class (including this analog): Same typology when stock is mixed plain/modified by availability or duration preference. forum
- Timing within the pair: Common talk is Semax-class morning / earlier day and Selank-class later (or both multi-dose); others dose together. Not standardized. forum
- Dose relationship talk: Not a universal ratio; people often run each agent in its own common band (e.g. hundreds of mcg nasal each) rather than a published blend math. Pre-mixed Semax/Selank vendor blends exist in some clinics/commerce — ratios vary. forum
- Noopept + Selank-class: Older nootropic-forum memory/focus + anxiety-control pairing. forum
- Caffeine / L-theanine layer: Common lifestyle stack; watch overstimulation if NA-Semax Amidate is also present. forum
- Racetams / other nootropics: Piracetam, phenylpiracetam, etc. in legacy stacks — confounds attribution. forum
- Dihexa / P21 / other cognitive peptides: Mentioned in aggressive nootropic stacks; sparse controlled data and hard to isolate effects. forum
- DSIP / sleep agents: Sometimes discussed when anxiety and sleep interact; separate goals from daytime calm. forum
- Stimulant meds (e.g. ADHD Rx): Harm-reduction threads ask about stacking Selank-class with prescribed stimulants; no solid interaction tables. forum
- Lifestyle co-credit: Sleep, caffeine reduction, therapy, and load management often co-credited with “NA-Selank worked.” forum
- Preserved multiple-calming-agents note: The frozen profile records anecdotal flatness, low motivation or cognitive dulling when Selank-class products were combined with other calming agents. The newly inspected exact-amidate threads do not independently verify that combination outcome. anecdote
- Preserved solo-attribution note: The frozen profile records a community practice of observing a Selank-class agent alone before adding other agents. The newly inspected exact-amidate threads do not establish a controlled combination outcome. forum
Storage notes
- No mix instructions here: STUDresearch does not list reconstitution, diluent volumes, or syringe unit charts. People reconstitute many different ways and vial labels differ — that content creates more confusion than clarity. forum
- Storage (general talk only): Unopened research products are usually kept cool, dry, and away from light per the seller label. Anything after first use is product-specific — follow the label, not a universal forum SOP. forum
Watch for
- Nasal irritation (most common): Burning, dryness, sneezing, runny nose, post-nasal drip / throat taste when solution runs posteriorly. forum
- Headache / sinus pressure: Mild head pressure or tension-type headache in a minority — often stacked with NA-Semax Amidate, dehydration, or sleep debt. forum
- Flat / fatigue / mild sedation: Over-calm, unmotivated flatness, or mild drowsiness — especially at higher discussed amounts or when stacked with other calming agents. Not classic benzo knock-out for most reporters, but a real minority complaint. forum
- Cognitive dulling / low mood: Minority Selank-class logs of sedation, cognitive impairment, or depression-like flatness — sometimes when stacked aggressively with other nootropics. anecdote
- Paradox mood / first-dose oddities: Rare worse anxiety, spacey head, nausea, hot/cold flashes, or brief elevated heart-rate awareness after nasal exposure (sometimes drip-related) appear in Selank-class anecdotes. anecdote
- Overstimulation / irritability: Less common than with Semax/NASA; occasionally reported at higher doses or in sensitive users. forum
- Injection-site issues (if SubQ): Redness, irritation, pin discomfort — minority route. forum
- Source / identity risk: Mislabel (plain Selank vs N-acetyl vs N-acetyl amidate), underfilled vials, wrong spray concentration, bacterial contamination of multi-use bottles. forum
- Regulatory: Research-chem status outside Russia; not FDA/EMA-approved; Russian registration of plain Selank 0.15% does not transfer to this analog. forum
- Dependence narrative gap: Community and parent-Selank summaries emphasize lack of classic benzo withdrawal — that is not proof of zero rebound anxiety after stopping a gray-market course or of long-term self-experimentation safety. forum
- Desensitization speculation: Some secondary sources warn continuous multi-week+ use might desensitize GABA-related systems; hard data for this analog is lacking — short courses remain the conservative discussion norm. forum
- Hair-loss / BDNF speculation: Occasional internet speculation linking BDNF-elevating agents to hair-loss risk in predisposed people; not established for Selank or NA-Selank Amidate. forum
- Not risk-free: “Research-only label” and short parent-molecule tolerability claims do not make uncontrolled self-experimentation with unknown purity risk-free. forum
- Evidence gap (critical): Clinical safety narratives and “well tolerated in short courses” language mostly describe plain Selank under Russian product/clinical conditions — not controlled NA-Amidate programs. Extrapolation is common and weakly justified. trial
- Interactions: No robust public interaction tables for SSRIs, SNRIs, benzos, alcohol, stimulants, or other peptides. Parent Selank animal work with diazepam exists in combination-pharmacology papers — not a human polypharmacy guide. trial
Evidence mix
Mostly community / anecdote tags
Full: every bullet (trial + community). Use Scan for a faster bro-science read.